Data recording and qualitative analysis by X-Ray Diffraction at grazing incidence.

X-Ray Diffraction data logging for qualitative and quantitative analysis.

Data logging with customer specifications.

Comparative analysis of Active Ingredients by superimposition of XRD profiles, without polymorph identification-Data logging.

Identification of polymorphs in Active Pharmaceutical Ingredients by X-ray Diffraction.

Advice on the Identification of Polymorphic Forms (Tablets – patent infringement case) by X-Ray Diffraction.

Identification of crystalline phases by X-Ray Diffraction (BULK, decantation separation: normal, ethylene glycol to check for the presence of expandable material, calcined at 550 °C).

Quantification of crystalline phases by X-Ray Diffraction (BULK, decantation separation: normal, ethylene glycol to check for the presence of expandable material, calcined at 550 °C).

Data logging by thermodiffraction.

Data logging: non-oriented clay samples (Bulk) and oriented samples: normal, glycol and calcined – Without sample preparation.

Identification of polymorphs in Active Pharmaceutical Ingredients by X-Ray Diffraction, without data recording.

Comparative analysis of Active Pharmaceutical Ingredients / finished products by superimposition of XRD profiles, without data logging.

Identification of the crystalline form present in a finished and semi-finished product by X-Ray Diffraction.

Differential Scanning Calorimetry – DSC analysis.

Thermogravimetric Analysis -TGA.

Simultaneous DSC-TGA analysis.

Data logging: Unoriented clay samples (Bulk) and oriented samples: normal, glycol and calcined.

Magaldrate identification by X-Ray Diffraction, according to USP specifications.

Identification of Diosmectite by Powder X-Ray Diffraction.

Quantification of crystalline phases by X-Ray Diffraction – No data recorded.

Identification of Aluminum and Magnesium Silicate by X-Ray Diffraction, according to USP-NF criteria 1 and 2.

Qualitative Analysis of Amorphous Active Pharmaceutical Ingredients.

Identification of cristobalite and other impurities in diosmectite by X-Ray Diffraction.

Quantitative elemental analysis by wavelength dispersive X-ray fluorescence. Combustible samples.

Quantitative elemental analysis by wavelength dispersive X-Ray Fluorescence in the Na-U range. Mineral and inorganic samples.

Quantitative elemental analysis by wavelength dispersive X-Ray Fluorescence in the Na-U range. Metallic Samples.

Quantitative analysis of SiO2 and Al2O3 by X-Ray Fluorescence in mineral Active Pharmaceutical Ingredients and in Diosmectite in suspension sachet.

Quantitative analysis of SiO2 and Al2O3 by X-Ray Fluorescence in finished mineral products and in Diosmectite in suspension sachets.

Data logging of single crystalline samples.

Resolution and structural refinement of single crystalline samples.